Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (42)
  • 2024 (39)
  • 2023 (25)
  • 2022 (36)
  • 2021 (69)
  • 2020 (49)
  • 2019 (54)
  • 2018 (47)
  • 2017 (38)
  • 2016 (22)
  • 2015 (16)
  • 2014 (22)
  • 2013 (39)
  • 2012 (8)
  • 2011 (32)

Subject

  • Outreach/Drug Prevention (56)
  • Drug Trafficking (48)
  • Take Back Day (47)
  • Fake Pills (32)
  • Prescription Drugs (32)
  • Fentanyl Awareness (31)
  • One Pill Can Kill (25)
  • Public and Media Affairs - also see Congressional Affairs (22)
  • Red Ribbon (21)
  • Overdose (19)
  • Prevention/Education - DEA websites GSAD, JTT etc (17)
  • Synthetic drugs (17)
  • Arrests/Convictions - Major (16)
  • Press Conferences (14)
  • Diversion Division (13)
  • Congressional Affairs (12)
  • Guns/Weapons (12)
  • Major Law Enforcement Operation (12)
  • Pharmaceuticals/Pharmacists/Physicians (11)
  • Seizures (Drugs/Property) (10)
  • Counterfeit Pills (6)
  • Money Laundering (6)
  • Fentanyl Free America (5)
  • Narcoterrorism (5)
  • OCDETF/Task Force (5)
  • Extraditions (4)
  • Gangs (4)
  • Guilty Plea (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Task Forces/Task Force Officers (4)
  • Campaigns (3)
  • Critical Incident (3)
  • HIDTA (3)
  • Other (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Recruitment/Office of Training/Graduations (1)

Drug Name

  • Fentanyl (64)
  • Methamphetamine (38)
  • Cocaine (26)
  • Heroin (20)
  • Marijuana (Cannabis) (10)
  • Oxycodone (6)
  • Synthetic Opioids (6)
  • Opioids (5)
  • Marijuana Concentrates (2)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • Sede (414)
  • Omaha (137)
Clear All Results
546 Results - Showing 281 to 290
PRESS RELEASE

DEA announces additional regulatory steps to address opioid epidemic

WASHINGTON – The Drug Enforcement Administration today announced proposed regulations to improve DEA’s ability to oversee the production of dangerous drugs at the height of the national opioid crisis. This proposed regulation would further limit excess quantities of medications that might be vulnerable to diversion for illicit distribution and use...
PRESS RELEASE

DEA Omaha Division kicks off Red Ribbon Week on October 23

OMAHA, Neb. –The Drug Enforcement Administration (DEA) Omaha Division kicks off Red Ribbon Week Wednesday, October 23, as agents across the five state division visit schools and provide drug awareness and drug safety education to students from kindergarten through high school. Agents in the Omaha area will visit schools in...
PRESS RELEASE

Former Honduran congressman Tony Hernández convicted of conspiring to import cocaine into the United States and related firearms and false-statements offenses

NEW YORK – On October 18, DEA Special Operations Division Special Agent in Charge Wendy C. Woolcock and U.S. Attorney for the Southern District of New York Geoffrey S. Berman announced that on a jury returned a guilty verdict against Juan Antonio Hernández Alvarado, aka “Tony Hernández,” on all four...
PRESS RELEASE

Mixtecas motorcycle club member sentenced to 28 years in federal prison

OMAHA, Neb. – A 14-month investigation by U.S. Drug Enforcement Administration agents in the Quad Cities Post of Duty helped put away 54-year old Mixtecas Motorcycle Club member Jerry Green for 28 years in federal prison after he pleaded guilty to distribution of methamphetamine, possession of two pipe bombs, possession...
PRESS RELEASE

DEA encourages communities nationwide to Go Red for Red Ribbon

WASHINGTON – Following the successful launch of the 2019 National Red Ribbon Campaign earlier this month with First Lady Melania Trump at the annual Red Ribbon Rally , DEA is encouraging communities nationwide to Go Red for Red Ribbon – an effort to continue the momentum and promote awareness of...
PRESS RELEASE

DEA to accept electronic vaping devices and cartridges as part of National Prescription Drug Take Back Day

WASHINGTON – With robust public participation over the course of 17 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...
PRESS RELEASE

First Lady Melania Trump kicks off National Red Ribbon Week with DEA

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...
PRESS RELEASE

DEA and FDA warn website operators illegally offering opioids for sale

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...
PRESS RELEASE

DEA proposes to control three precursor chemicals used to illicitly manufacture deadly fentanyl

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...
PRESS RELEASE

DEA proposes to reduce the amount of five opioids manufactured in 2020, marijuana quota for research increases by almost a third

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...

Paginación

  • Primera página «
  • Anterior
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster